A*STAR’s GIS scientists develop new program that may predict treatment targets for cancer In recent months, several national initiatives for personalized medicine have been announced, including the launched precision medicine initiative in the US recently, driven by quick advances in genomic technologies and with the promise of cheaper and better healthcare. Significant challenges stay, however, in the analysis and management of genetic information and their integration with patient data. The sheer level and complexity of this data, generated using cutting-edge technology such as next generation DNA sequencing, requires the development of new personal computers and algorithms that can mine this data to get actionable knowledge http://www.eriacta100.org .
ASTRO commends the FDA on holding this meeting to identify current issues and further develop data, which will help inform the FDA’s activities to ensure the highest level of security for radiation therapy individuals. Related StoriesUM SOM researchers to initiate first scientific trial of GammaPod system in sufferers with early-stage breasts cancerUniversity of Maryland evolves GammaPod system to treat early-stage breast cancerStudy may help mitigate ramifications of ageing on bloodstream stem cells, promote fresh therapies for anaemiaNumerous professionals from rays therapy community, including those from medical practice, academia and these devices industry, gathered to handle basic safety in radiation therapy.